Spinal astrocytes produce and secrete dynorphin neuropeptides

Neuropeptides

Volumn 47, Issue 2, 2013, Pages 109-115

  Wahlert, Andrew ^a   Funkelstein, Lydiane ^a   Fitzsimmons, Bethany ^b   Yaksh, Tony ^b   Hook, Vivian ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d San Diego   (United States)

Author keywords

Astrocyte; Dynorphins; Pain processing; Secretion; Spinal cord

Indexed keywords

ALPHA NEOENDORPHIN; DYNORPHIN A; DYNORPHIN A[1-7]; DYNORPHIN B; NEUROPEPTIDE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CELL CULTURE; CELL LEVEL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RADIOIMMUNOASSAY; RAT; SPINAL PAIN;

ADENOSINE TRIPHOSPHATE; ANIMALS; ASTROCYTES; CELLS, CULTURED; DYNORPHINS; ENDORPHINS; EXTRACELLULAR SPACE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; NEUROPEPTIDES; PAIN; PREGNANCY; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2X; SPINAL CORD; TOLL-LIKE RECEPTOR 4;

RATTUS;

EID: 84875269231     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2012.10.006     Document Type: Article

References (74)

1. Abbracchio M.P., Burnstock G., Verkhratsky A., Zimmermann H. Purinergic signaling in the nervous system: an overview. Trends Neurosci. 2009, 32:19-29.
2. Abraham K.E., McGinty J.F., Brewer K.L. Spinal and supraspinal changes in opioid mRNA expression are related to the onset of pain behaviors following excitotoxic spinal cord injury. Pain 2001, 90:181-190.
3. Allsopp R.C., El Ajouz S., Schmid R., Evans R.J. Cysteine scanning mutagenesis (residues Glu52-Gly96) of the human P2X1 receptor for ATP: mapping agonist binding and channel gating. J. Biol. Chem. 2011, 286:29207-29217.
4. Anderson C.M., Bergher J.P., Swanson R.A. ATP-induced ATP release from astrocytes. J. Neurochem. 2004, 88:246-256.
5. Baba H., Nakahira K., Morita N., Tanaka F., Akita H., Ikenaka K. GFAP gene expression during development of astrocyte. Dev. Neurosci. 1997, 19:49-57.
6. Bateman R.C., Hersh L.B. Mechanism based design of inhibitors of neuropeptide degrading enzymes. Drug Des. Deliv. 1987, 2:55-68.
7. Beinfeld M.C., Funkelstein L., Foulon T., Cadel S., Kitagawa K., Toneff T., Reinheckel T., Peters C., Hook V. Cathepsin L plays a major role in cholecystokinin production in mouse brain and in pituitary AtT-20 cells: protease gene knockout and inhibitor studies. Peptides 2009, 30:1882-1991.
8. Bergersen L.H., Gundersen V. Morphological evidence for vesicular glutamate release from astrocytes. Neuroscience 2009, 158:260-265.
9. Bowman C.C., Rasley A., Tranguch S.L., Marriott I. Cultured astrocytes express toll-like receptors for bacterial products. Glia 2003, 43:281-291.
10. Boyer J.L., Harden T.K. Irreversible activation of phospholipase C-coupled P2Y-purinergic receptors by 3'-O-(4-benzoylbenzoyl) adenosine 5'-triphosphate. Mol. Pharmacol. 1989, 36:831-835.
11. Bsibsi M., Ravid R., Gveric D., van Noort J.M. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 2002, 61:1013-1021.
12. Carrasquero L.M., Delicado E.G., Bustillo D., Gutierrez-Martin Y., Artalejo A.R., Miras-Portugal M.T. P2X7 and P2Y13 purinergic receptors mediate intracellular calcium responses to BzATP in rat cerebellar astrocytes. J. Neurochem. 2009, 110:879-889.
13. Christianson C.A., Fitzsimmons B.L., Shim J.H., Agrawal A., Cohen S.M., Hua X.Y., Yaksh T.L. Spinal TLR4 mediates the transition to a persistent mechanical hypersensitivity after the resolution of inflammation in serum-transferred arthritis. Neuroscience 2012, 200:199-210.
14. Civelli O., Douglass J., Goldstein A., Herbert E. Sequence and expression of the rat prodynorphin gene. Proc. Natl. Acad. Sci. USA 1985, 82:4291-4295.
15. Conigrave A.D., lee J.Y., van der Weyden L., Jiang L., Ward P., Tasevski V., Luttrell B.M., Morris M.B. Pharmacological profile of a novel cyclic AMP-linked P2 receptor on undifferentiated HL-60 leukemia cells. Br. J. Pharmacol. 1998, 124:1580.
16. De Leo J.A., Tawfik V.L., LaCroix-Fralish M.L. The tetrapartite synapse: path to CNS sensitization and chronic pain. Pain 2006, 122:17-21.
17. Draisci G., Kajander K.C., Dubner R., Bennett G.J., Iadarola M.J. Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Res. 1991, 560:186-192.
18. Duan S., Anderson C.M., Keung E.C., Chen Y., Chen Y., Swanson R.A. P2X7 receptor-mediated release of excitatory amino acids from astrocytes. J. Neurosci. 2003, 23:1320-1328.
19. Dubner R., Ruda M.A. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 1992, 15:96-103.
20. Evans C.J., Barchas J.D., Esch F.S., Böhlen P., Weber E. Isolation and characterization of an endogenous C-terminal fragment of the alpha-neo-endorphin/dynorphin precursor from bovine caudate nucleus. J. Neurosci. 1985, 5:1803-1807.
21. Evans R.J., Lewis C., Buell G., Valera S., North R.A., Surprenant A. Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2xpurinoceptors). Mol. Pharmacol. 1995, 48:178-183.
22. Funkelstein L., Toneff T., Hwang S.R., Beuschlein F., Lichtenauer U.D., Reinheckel T., Peters C., Hook V. Major role of cathepsin L for producing the peptide hormones ACTH, beta-endorphin, and alpha-MSH, illustrated by protease gene knockout and expression. J. Biol. Chem. 2008, 83:35652-35659.
23. Funkelstein L., Toneff T., Hwang S.R., Reinheckel T., Peters C., Hook V. Cathepsin L participates in the production of neuropeptide Y in secretory vesicles, demonstrated by protease gene knockout and expression. J. Neurochem. 2008, 106:384-391.
24. Funkelstein L., Lu W.D., Koch B., Mosier C., Toneff T., Taupenot L., O'Connor D.T., Reinheckel T., Peters C., Hook V. Human cathepsin V produces enkephalin and NPY neurotransmitters by processing proneuropeptides. J. Biol. Chem. 2012, (Epub ahead of print).
25. Gao Y.J., Ji R.R. Targeting astrocyte signaling for chronic pain. Neurotherapeutics 2010, 7:482-493.
26. Gaumann D.M., Grabow T.S., Yaksh T.L., Casey S.J., Rodriguez M. Intrathecal somatostatin, somatostatin analogs, substance P analog and dynorphin A cause comparable neurotoxicity in rats. Neuroscience 1990, 39:761-774.
27. Gwak Y.S., Kang J., Unabia G.C., Hulsebosch C.E. Spatial and temporal activation of spinal glial cells: role of gliopathy in central neuropathic pain following spinal cord injury in rats. Exp. Neurol. 2012, 234:362-372.
28. Hald A. Spinal astrogliosis in pain models: cause and effects. Cell. Mol. Neurobiol. 2009, 29:609-619.
29. Headrick J.P., Faden A.I., Vink R. Intrathecal dynorphin-A infusion in rat spinal cord causes energy depletion, edema and neurologic dysfunction. Neurochem. Int. 1995, 26:489-495.
30. Iadarola M.J., Brady L.S., Draisci G., Dubner R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain 1988, 35:313-326.
31. Inagaki N., Fukui H., Ito S., Wada H. Type-2 astrocytes show intracellular Ca2+ elevation in response to various neuroactive substances. Neurosci. Lett. 1991, 128:257-260.
32. Jack C.S., Arbour N., Manusow J., Montgrain V., Biain M., McCrea E., Shapiro A., Antel J.P. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 2005, 175:4320-4330.
33. Jarvis M.F. The neural-glial purinergic receptor ensemble in chronic pain states. Trends Neurosci. 2010, 33:48-57.
34. Ji R.R., Befort K., Brenner G.J., Woolf C.J. ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity. J. Neurosci. 2002, 22:478-485.
35. Kajander K.C., Sahara Y., Iadarola M.J., Bennett G.J. Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy. Peptides 1990, 11:719-728.
36. Koetzner L., Hua X.Y., Lai J., Porrerca F., Yaksh T. Nonopioid actions of intrathecal dynorphin evoke spinal excitatory amino acid and prostaglandin E2 release mediated by cyclooxygenase-1 and -2. J. Neurosci. 2004, 24:1451-1458.
37. Komatsu T., Sakurada S., Katsuyama S., Sanai K., Sakurada T. Mechanism of allodynia evoked by intrathecal morphine-3-glucuronide in mice. Int. Rev. Neurobiol. 2009, 85:207-219.
38. Kovac S., Shulkes A., Baldwin G.S. Peptide processing and biology in human disease. Curr. Opin. Endocrinol. Diabetes Obes. 2009, 16:79-85.
39. Kreft M., Stenovec M., Rupnik M., Grilc S., Krzan M., Potokar M., Pangrsic T., Haydon P.G., Zorec R. Properties of Ca(2+)-dependent exocytosis in cultured astrocytes. Glia 2004, 46:437-445.
40. Krzan M., Stenovec M., Kreft M., Pangrsic T., Grilc S., Haydon P.G., Zorec R. Calcium-dependent exocytosis of atrial natriuretic peptide from astrocytes. J. Neurosci. 2003, 23:1580-1583.
41. Malan T.P., Ossipov M.H., Gardell L.R., Ibrahim M., Bian D., Lai Porreca J.F. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats. Pain 2000, 86:185-194.
42. Mika J., Obara I., Przewlocka B. The role of nociceptin and dynorphin in chronic pain: implications of neuro-glial interaction. Neuropeptides 2011, 45:247-261.
43. Miller R.J., Jung H., Bhangoo S.K., White F.A. Cytokine and chemokine regulation of sensory neuron function. Handb. Exp. Pharmacol. 2009, 194:417-449.
44. Minokadeh A., Funklestein L., Toneff T., Hwang S.R., Reinheckel T., Peters C., Zadina J., Hook V. Cathepsin L participates in dynorphin neuropeptide production in brain cortex, illustrated by protease gene knockout and expression. Mol. Cell. Neurosci. 2010, 43:98-107.
45. Montana V., Malarkey E.B., Verderio C., Matteoli M., Parpura V. Vesicular transmitter release from astrocytes. Glia 2006, 54:700-715.
46. Nagasaka H., Awad H., Yaksh T.L. Peripheral and spinal actions of opioids in the blockade of the autonomic response evoked by compression of the inflamed knee joint. Anesthesiology 1996, 85:808-816.
47. Neary J.T., Baker L., Jorgensen S.L., Norenberg M.D. Extracellular ATP induces stellation and increases glial fibrillary acidic protein content and DNA synthesis in primary astrocyte cultures. Acta Neuropathol. 1994, 87:8-13.
48. Nichols M.L., Lopez Y., Ossipov M.H., Bian D., Porreca F. Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy. Pain 1997, 69:317-322.
49. Paco S., Margelí M.A., Olkkonen V.M., Imai A., Blasi J., Fischer-Colbrie R., Aguado F. Regulation of exocytotic protein expression and Ca2+-dependent peptide secretion in astrocytes. J. Neurochem. 2009, 110:143-156.
50. Pelissie T., Paeile C., Soto-Moyano R., Saavedra H., Hernández A. Analgesia produced by intrathecal administration of the kappa opioid agonist, U-50,488H, on formalin-evoked cutaneous pain in the rat. Eur. J. Pharmacol. 1990, 190:287-293.
51. Priller J., Reddington M., Haas C.A., Kreutzberg G.W. Stimulation of P2Y-purinoceptors on astrocytes results in immediate early gene expression and potentiation of neuropeptide action. Neuroscience 1998, 85:521-525.
52. Rochford J., Godin C., Henry J.L. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: medication by a nonopioid mechanism. Brain Res. 1991, 565:67-77.
53. Saito O., Svensson C.I., Buczynski M.W., Wegner K., Hua X.Y., Codeluppi S., Schaloske R.H., Deems R.A., Dennis E.A., Yaksh T.L. Spinal glial TLR-4 mediated nociception and production of prostaglandins E(2) and TNF. Br. J. Pharmacol. 2010, 160:1754-1764.
54. Schmauss C., Yaksh T.L. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. J. Pharmacol. Exp. Ther. 1984, 228:1-12.
55. Schwartz J.P., Wilson D.J. Preparation and characterization of type 1 astrocytes cultured from adult rat cortex, cerebellum, and striatum. Glia 1992, 5:75-80.
56. Shimoyama M., Tatsuoka H., Ohtori S., Tanaka K., Shimoyama N. Change of dorsal horn neurochemistry in a mouse model of neuropathic cancer pain. Pain 2005, 114:221-230.
57. Stevens C.W., Yaksh T.L. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity. J. Pharmacol. Exp. Ther. 1986, 238:833-838.
58. Shinoda H., Marini A.M., Cosi C., Schwartz J.P. Brain region and gene specificity of neuropeptide gene expression in cultured astrocytes. Science 1989, 245:415-417.
59. Sims K., Haynes C.A., Kelly S., Allegood J.C., Wang E., Momin A., Leipelt M., Reichart D., Glass C.K., Sullards M.C., Merrill A.H. Kdo2-lipid A, a TLR4-specific agonist, induces de novo sphingolipid biosynthesis in RAW264.7 macrophages, which is essential for induction of autophagy. J. Biol. Chem. 2010, 285:38568-38579.
60. Sobota J.A., Ferraro F., Bäck N., Eipper B.A., Mains R.E. Not all secretory granules are created equal: Partitioning of soluble content proteins. Mol. Biol. Cell 2006, 17:5038-5052.
61. Stevens B. Neuron-astrocyte signaling in the development and plasticity of neural circuits. Neurosignals 2008, 16:278-288.
62. Stevens B., Fields R.D. Response of Schwann cells to action potentials in development. Science 2000, 287:2267-2271.
63. Suadicani S.O., Brosnan C.F., Scemes E. P2X7 receptors mediate ATP release and amplificaiton of astrocytic intercellular Ca2+ signaling. J. Neurosci. 2006, 26:1378-1385.
64. Svensson C.I., Brodin E. Spinal astrocytes in pain processing: non-neuronal cells as therapeutic targets. Mol. Interv. 2010, 10:25-38.
65. Svensson C.I., Hua X.Y., Powell H.C., Lai J., Porreca F., Yaksh T.L. Prostaglandin E(2) release evoked by intrathecal dynorphin is dependent on spinal p38 mitogen activated protein kinase. Neuropeptides 2005, 39:485-494.
66. Tan-No K., Esashi A., Nakagawasai O., Niijima F., Tadano T., Sakurada C., Sakurada T., Bakalkin G., Terenius L., Kisara K. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-d-aspartate receptor mechanism. Brain Res. 2002, 952:7-14.
67. Verderio C., Cagnoli C., Bergami M., Francolini M., Schenk U., Colombo A., Riganti L., Frassoni C., Zuccaro E., Danglot L., Wilhelm C., Galli T., Canossa M., Matteoli M. TI-VAMP/VAMP7 is the SNARE of secretory lysosomes contributing to ATP secretion from astrocytes. Biol. Cell 2012, 104:213-228.
68. Verderio C., Coco S., Rossetto O., Montecucco C., Matteoli M. Internatlization and proteolytic action of botulinum toxins in CNS neurons and astrocytes. J. Neurochem. 1999, 73:372-379.
69. Vilijn M.H., Vaysse P.J., Zukin R.S., Kessler J.A. Expression of preproenkephalin mRNA by cultured astrocytes and neurons. Proc. Natl. Acad. Sci. USA 1988, 85:6551-6555.
70. Wang Z., Gardell L.W., Ossipov M.H., Vanderah T.W., Brennan M.B., Hochgeschwende U., Hruby V.J., Malan T.P., Lai J., Porreca F. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J. Neurosci. 2001, 21:1779-1786.
71. Watkins L.R., Maier S.F. GLIA: a novel drug discovery target for clinical pain. Nat. Rev. Drug Discov. 2003, 2:973-985.
72. Werry E.L., Liu G.J., Bennett M.R. Glutamate-stimulated ATP release from spinal astrocytes is potentiated by substance P. J. Neurochem. 2006, 99:924-936.
73. Wismer C.T., Falktynek C.R., Jarvis M.R., McGaraughty S. Distinct neurochemical mechanisms are activated following administration of different P2X receptor agonists into the hindpaw of a rat. Brain Res. 2003, 965:187-193.
74. Xu Q., Yaksh T.L. A brief comparison of the pathophysiology of inflammatory versus neuropathic pain. Curr. Opin. Anaesthesiol. 2011, 24:400-407.